SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058840
Filing Date
2021-11-15
Accepted
2021-11-12 19:20:57
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_adialpharm.htm   iXBRL 10-Q 677224
2 CERTIFICATION f10q0921ex31-1_adialpharm.htm EX-31.1 10484
3 CERTIFICATION f10q0921ex31-2_adialpharm.htm EX-31.2 10448
4 CERTIFICATION f10q0921ex32-1_adialpharm.htm EX-32.1 4282
5 CERTIFICATION f10q0921ex32-2_adialpharm.htm EX-32.2 4301
  Complete submission text file 0001213900-21-058840.txt   4396247

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20210930.xsd EX-101.SCH 64591
7 XBRL CALCULATION FILE adil-20210930_cal.xml EX-101.CAL 27689
8 XBRL DEFINITION FILE adil-20210930_def.xml EX-101.DEF 241788
9 XBRL LABEL FILE adil-20210930_lab.xml EX-101.LAB 509980
10 XBRL PRESENTATION FILE adil-20210930_pre.xml EX-101.PRE 255893
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_adialpharm_htm.xml XML 437555
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 211405612
SIC: 2834 Pharmaceutical Preparations